Subject Index
Coagulation Factors and Inhibitors
Fibrinolysis, fibrinogen, fibrin
Haemorrhagic Disorders
Invited
Other
Platelets
Thrombotic Disorders and antithrombotic therapy
Vascular Biology
Thrombotic Disorders and antithrombotic therapy
Animal and experimental models
Antiphospholipid antibodies
Cancer and thrombosis
Cerebrovascular disease
Clinical trials: antiplatelet agents
Clinical trials: direct antithrombin agents
Clinical trials: fibrinolytic therapy
Clinical trials: heparins/LMWH
Clinical trials: oral anticoagulants
Diabetes and metabolic disorders
DVT and pulmonary embolism
Familial thrombosis
Gene therapy
Genetic determinants and epidemiology
Homocysteine
Hormone, pregnancy
Hypercoagulability
Inflammation, infection and immunity
Ischaemic heart disease
New antithrombotic agents and approaches
New intravascular devices
Other thrombotic disorders and antithrombotic therapy
Polymorphism and arterial disease
TTP and HUS
A comparative study of new generation blood sampling tubes for thrombophilia investigations
Smith J. M., Bowyer A. E., Cooper P. C., Pastorelli D., Makris M., Kitchen S.
Accuracy of laboratory diagnosis of familial thrombophilia, 2001–2002: UK NEQAS experience
Preston F. E., Jennings I., Kitchen S., Woods T. A. L.
Clinical data of subjects with Factor V Leiden or G20210A prothrombin mutation: a single institution experience
Iannaccaro P., Santaro R., Muleo G.
Congenital defect of inferior vena cava and thrombophilia Leiden
Makris P. E., Girtovitis F., Lazaraki G., Kosmidou M., Anestakis D., Papadopoulos A., Ziakas G.
Contribution of factor V deficiency to the thrombotic risk associated with factor V HR2
Faioni E. M., Castaman G., Asti D., Lussana F., Rodeghiero F.
Elevated factor VIIIC and further prothrombotic risk factors in paediatric venous thrombosis and stroke: a multivariate analysis
Nowak-Goettl U., Schulte T., Kurnik K., Heller C. H., Schobess R., Junker R.
Emotional impact of testing for inherited thrombophilia
Legnani C., Razzaboni E., Gremigni P., Ricci Bitti P. E., Palareti G.
Familial segregation of venous thromboembolism
Hiet J. A., Phelps M. A., Ward S. A., Slusser J. P., Petterson T. M., De Andrade M.
Family history of thromboembolism does not identify children with thrombophilia – A cross-sectional study
Ruud E., Holmstrøm H., Brosstad F., Wesenberg F.
Functional analysis of the prothrombin (PT) G20210A variation
Ceelie H., Spaargaren-Van Riel C. C., Bertina R. M., Vos H. L.
Hemostatic parameters in Brazilian asymptomatic carriers of Factor V Leiden, prothrombin (G20210A) and methylenetetrahydrofolate reductase (C677T) mutations
Godoi L. C., Carvalho M. G., Fernandes A. P. S. M., Vieira L. M., Giumarães D. A. M., Lages G. F. G., Bragança W. F., Souza R. C. C., Abrão R. C. O., Dusse L. M. S.
Heritability of clotting factors and the prothrombotic state: results from a large thrombophilic pedigree of French Canadian descent with Type I protein C deficiency
Vossen C., Hasstedt S. J., Rosendaal F. R., Bauer K. A., Broze G. J., Long G. L., Scott B. T., Callas P. W., Bovill E. G.
Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
Vossen C. Y., Conard J., Fontcuberta J., De Jonge I., Makris M., Van Der Meer F. J. M., Pabinger I., Palareti G., Preston F. E., Scharrer I., Souto J. C., Svensson P., Walker I. D., Rosendaal F. R.
Increased risk for venous thromboembolism and myocardial infarction in family members of patients with prothrombin 20210 A mutation
Bank I., Libourel E. J., Middeldorp S., Hamulyak K., Van Der Meer J., Koopman M. M. W., Van Pampus E. C. M., Prins M. H., Buller H. R.
Inherited prothrombotic risk factors in a Brazilian cohort with CVT
D'Amico E., Camargo E. C. S., Villaça P. R., Massaro A. R., Bassitt R. P., Bendit I., Silva C. S. S., Bacheschi L. A., Scaff M., Chamone D. A. F.
Lower degree of protein C activation in protein C deficient individuals of a large kindred with type I PC deficiency, as measured by the level of APC-PCI complex
Vossen C., Van Korlaar I., Rosendaal F., Naud S. J., Callas P. W., Long G. L., Bovill E.
Pilot introduction study of a needleless transfer device (BAXJECT) for reconstitution of Factor VIII concentrates for infusion
Leissinger C., Nuss R., Wulff K., Giambartolomei S., Raith C., Urbancik W., Spotts G.
Prolonged prophylaxis against VTE with enoxaparin in patients undergoing surgery for malignancy: 1-year survival study
Bergqvist D., Agnelli G., Cohen A. T., Nilsson P. E., Le Moigne-Amrani A., Dietrich-Neto F.
Psychologic impact of thrombophilia screening in asymptomatic relatives of carriers of prothrombotic mutations
Torrano-Masetti L., Rizzatti E. G., Oliveira L. C. O., Inácio R. A., Santos M. A., Franco R. F.
Quality of life and risk perception in a large family with heritable protein C deficiency (IPCI: International Protein C Investigation)
Van Korlaar I., Vossen C. Y., Emmerich J., Long G., Rosendaal F. R., Bovill E. G., Naud S., Callas P., Kaptein A. A.
Questioning the questionnaire: a sensitivity analysis for data collection on venous thrombosis
Vossen C. Y., Van Korlaar I. M., Rosendaal F. R., Cushman M., Bovill E. G.
Risk for recurrent venous thromboembolism after a first superficial vein thrombosis among carriers of inherited thrombophilia
De Stefano V., Rossi E., D'Orazio A., Za T., Leone G.
Risk for recurrent venous thromboembolism among patients with severe inherited thrombophilia
De Stefano V., Martenelli I., Legani C., Rossi E., Grandone E., Castaman G., Palareti G., Mannucci P. M., Leone G.
Risk for venous thromboembolism among younger or older carriers of inherited thrombophilia
De Stefano V., Rossi E., D'Orazio A., Za T., Leone G.
Risk for venous thrombosis in unusual sites associated with inherited thrombophilia: analysis of 133 patients
De Stefano V., Rossi E., D'Orazio A., Za T., Leone T.
Risk of pregnancy-related venous thromboembolism (VTE) in 60 hereditary AT-deficient women from 45 families: study of 164 pregnancies
Conard J., Mathieux V., Horellou M. H., Elalamy I., Samama M. M.
Risk of venous thromboembolism during pregnancy and puerperium in women with homozygous form of F V Leiden
Dulicek P., Slechtova M., Maly J., Bulikova A., Beranek M., Penka M., Pacejka M.
Severe thrombophilia in two brothers due to novel combination of mutations in factor V gene producing quantitative deficiency (Glu119Term) and decreased sensitivity to activated protein C due to a novel glycosylation site (Ile359Thr-FV Liverpool)
Bolton-Maggs P., Mumford A., Mcvey J., Tuddenham E. G. D., Steen M., Norstrom E., Dahlback B.
The 46C®T polymorphism in the F12 gene as a risk factor for venous thrombosis: association after linkage analysis
Tirado I., Soria J. M., Mateo J., Oliver A., Souto J. C., Vallve C., Santamaria A., Borrell M., Fontcuberta J.
The Factor V HR2 haplotype and the risk of venous thrombosis: a metanalysis
Castaman G., Faioni E. M., Tosetto A., Bernardi F.
The incidence of venous thromboembolism in carriers of single identified prothrombin G20210A: a retrospective cohort study
Simioni P., Zerbinati P., Luni S., Fadin M., Gavasso S., Tognin G., Prandoni P., Girolami A., Tormene D.
The incidence of venous thromboembolism in double-heterozygous carriers of antithrombin, protein C and protein S deficiency and HR2 haplotype
Tormene D., Simioni P., Fortuna S., Zerbinati P., Tognin G., Prandoni P., Girolami A.
The incidence of venous thromboembolism in homozygous or double heterozygous carriers of the factor V Leiden mutation, prothrombin 20210 A mutation and HR2 aplotype: interim report
Tormene D., Simioni P., Luni S., Zerbinati P., Fadin M., Gavasso S., Tognin G., Prandoni P., Girolami A.
The risk of pregnancy complications in women from families with thrombophilic defects
Middeldorp S., Bank I., Libourel E. J., Hamulyak K., Van Der Meer J., Koopman M. M. W., Van Pampus E. C. M., Prins M. H., Buller H. R.
The strong incidence of acquired and inherited thrombophilia in recurrent first trimester fetal loss
Ciampa A., Manzo A., Grandone E., Margaglione M., Volpe E.
Thrombophilia and pregnancy
Papaioannou G., Speletas M., Chasapopoulou H., Kioumi A., Rafail S., Katodritou E., Korantzis I.
Venous and arterial thromboembolic risk in first degree family members of patients with elevated plasma levels of clotting factor VIII:c
Bank I., Libourel E. J., Middledorp S., Hamulyak K., Van Der Meer J., Koopman M. M. W., Van Pampus E. C. M., Prins M. H., Buller H. R.
Warfarin-induced skin necrosis in a child with protein C deficiency and Factor V Leiden mutation
Curtin J. A., Lammi A. T., Webster B. H.